A master protocol to investigate a novel therapy acetyl-L-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 Gangliosidoses, and Ataxia Telangiectasia
Taylor Fields, Marc Patterson, Tatiana Bremova, Glyn Belcher, Ian Billington, Grant C Churchill, William Davis, William Evans, Susan Flint, Antony Galione, Ulrich Granzer, Julia Greenfield, Rick Karl, Richard Kay, Dan Lewi, Toni Mathieson, Thorsten Meyer, Diana Pangonis, Frances M Platt, Lincoln Tsang, Christa Verburg, Mallory Factor, Michael Strupp
medRxiv 2020.03.11.20034256; doi: https://doi.org/10.1101/2020.03.11.20034256
